[Federal Register Volume 82, Number 52 (Monday, March 20, 2017)]
[Notices]
[Pages 14366-14367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05417]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Identification and Characterization of the Infectious Disease 
Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; 
Public Workshop; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Thursday, December 29, 2016. 
The document announced a

[[Page 14367]]

public workshop entitled ``Identification and Characterization of the 
Infectious Disease Risks of Human Cells, Tissues, and Cellular and 
Tissue-based Products.'' The document was published with an error in 
the Web site address to access the transcript of the workshop. This 
document corrects that error.

FOR FURTHER INFORMATION CONTACT: Monica Kapoor, Center for Biologics 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 71, Rm. 3111C, Silver Spring, MD 20993, 
[email protected]; or Staci Revette, Center for Biologics 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 71, Rm. 3109B, Silver Spring, MD 20993, 
[email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of Thursday, 
December 29, 2016, in FR Doc. 2016-31628, on page 96008, the following 
correction is made:
    On page 96008, in the second column under the Transcripts caption 
of section III, Participating in the Public Workshop, the third 
sentence in the fourth paragraph is corrected to read, ``Please be 
advised that as soon as a transcript of the public workshop is 
available, it will be accessible at: http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm525001.htm.''

    Dated: March 14, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-05417 Filed 3-17-17; 8:45 am]
BILLING CODE 4164-01-P